Filter posts

BIO Innovation Zone Company Snapshots: Delsys, Immunetics, and Advanced Plasma Products

Next week in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes …

BIO Innovation Zone Company Snapshots: Giner, GigaGen, and Synthonics

Later this month in Philadelphia at the BIO International Convention, BIO will be partnering with the …

BIO Innovation Zone Company Snapshots: GlycoMira Therapeutics, TheraSource, and Biomedica Management

Later this month in Philadelphia at the BIO International Convention, BIO will be partnering with the …

Dr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards Program

Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes …

BIO Patient & Health Advocacy Summit: The Power of Partnerships

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to …

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its …

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology …

21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle

How can we give patients faster access to innovative treatments and cures? That’s the question …

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading …

Expand Investment in Basic Research Needed to Advance Medical Progress

In 2007, the Napier and Lane families struggled to find answers to their daughters’ developmental …